Hepatitis in clinical practice

References

• Couch RB. Miscellaneous viral diseases. In: Stringfellow DA. ed. Virology. Kalamazoo. MI: Upjohn. 1983: 105–17
   Google Scholar
• Robinson WS. Hepatitis A. In: Hoeprich PD. ed. Infectious diseases: a modern treatise of infectious processes. 3d ed. New York: Harper & Row, 1983: 705–13
   Google Scholar
• Robinson WS. Hepatitis A virus. In: Mandell GL. Douglas RG, Bennett JE. eds. Principles and practice of infectious diseases. 2d ed. New York: J Wiley. 1985: 829–40
   Google Scholar
• Hollinger FB, Khan NC, Oefinger PE, et al. Posttransfusion hepatitis type A. JAMA 1983: 250(17): 2313–7
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Outbreak of food-borne hepatitis A—New Jersey. MMWR 1982: 31(12): 150–2
   PubMedGoogle Scholar
• Goodman RA, Carder CC, Allen JR. et al. Nosocomial hepatitis A transmission by an adult patient with diarrhea. Am J Med 1982: 73(2): 220–6
   PubMed Web of Science ®Google Scholar
• Hadler SC, Webster HM, Erben JJ, et al. Hepatitis A in day-care centers: a community-wide assessment. N Engl J Med 1980: 302(22): 1222–7
   PubMed Web of Science ®Google Scholar
• Hadler SC. Viral hepatitis type A infection. Symposium: infectious diseases in child day care. Proceedings of the 23d Interscience Conference on Antimicrobial Agents and Chemotherapy. Las Vegas: 1983
   Google Scholar
• Portnoy BL, Mackowiak PA, Caraway CT, et al. Oyster-associated hepatitis: failure of shellfish certification programs to prevent outbreaks. JAMA 1975: 233(10): 1065–8
   PubMed Web of Science ®Google Scholar
• Oxman MN, Richman DD, Spector SA. Management at delivery of mother and infant when herpes simplex, varicella-zoster, hepatitis, or tuberculosis have occurred during pregnancy. In: Remington JS, Swartz MN. eds. Current clinical topics in infectious diseases Vol 4. New York: McGraw-Hill. 1983: 224–80
   Google Scholar
• Robinson WS. Hepatitis A virus. In: Mandell GL. Douglas RG. Bennett JE. eds. Principles and practice of infectious diseases. Vol 2. New York: J Wiley. 1979: 1370–88
   Google Scholar
• Storch GA, Bodicky C, Parker M, et al. Use of conventional and IgM-specific radioimmunoassays for anti-hepatitis A antibody in an outbreak of hepatitis A. Am J Med 1982: 73(5): 663–8
   PubMed Web of Science ®Google Scholar
• Perrillo RP. Differentiation between recent and remote hepatitis infections. IM—Intern Med 1984: 5(6): 123–42
   Google Scholar
• Robinson WS. Hepatitis B. In: Hoeprich PD, ed.2 pp 714–28
   Google Scholar
• Robinson WS. Hepatitis B virus and the delta agent. In: Mandell et al, eds,3 pp 1002–29
   Google Scholar
• Hirschman SZ. The hepatitis B vaccine: current recommendations for use. Drug Ther 1983: 13(Feb): 317–24
   Google Scholar
• Schafritz DA, Sherman M. Hepatitis B virus and hepatocellular carcinoma. In: Petersdorf RG, Adams RD, Braunwald E. et al, eds. Harrison's principles of internal medicine. Update V. New York: McGraw-Hill. 1984: 117–37
   Google Scholar
• Hoefs JC, Renner IG, Askhcavai M, et al. Hepatitis B surface antigen in pancreatic and biliary secretions. Gastroenterology 1980: 79(2): 191–4
   PubMed Web of Science ®Google Scholar
• Shimoda T, Shikata T, Karasawa T, et al. Light microscopic localization of hepatitis B virus antigens in the human pancreas: possibility of multiplication of hepatitis B virus in the human pancreas. Gastroenterology 1981: 81(6): 998–1005
   PubMed Web of Science ®Google Scholar
• Romet-Lemonne JL, McLane MF, Elfassi E, et al. Hepatitis B virus infection in cultured human lymphoblastoid cells. Science 1983: 221(4611): 667–9
   PubMed Web of Science ®Google Scholar
• Leichtner AM, Leclair J, Goldmann DA, et al. Horizontal nonparenteral spread of hepatitis B among children. Ann Intern Med 1981: 94(3): 346–9
   PubMed Web of Science ®Google Scholar
• Gottlieb N, Hyer FH. Hepatitis B virus (HBV) infection and rheumatic syndromes. IM—Intern Med 1984: 5(5): 49–53
   Google Scholar
• Shusterman N, London WT. Hepatitis B and immune-complex disease. N Engl J Med 1984: 310(1): 43–6
   PubMed Web of Science ®Google Scholar
• Gardner DF, Carithers RL Jr. Utiger RD. Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Ann Intern Med 1982: 96(4): 450–2
   PubMed Web of Science ®Google Scholar
• Conte JE Jr, Barriere SL. Viral hepatitis: clinical and serological summary. In: Conte JE Jr, Barriere SL, eds. Manual of antibiotics and infectious diseases. 5th ed. Philadelphia: Lea & Febiger. 1984: 263–92
   Google Scholar
• Kutcher WL. The new hepatitis B vaccine: how, when, and why to use it. Postgrad Med 1983: 73(5): 87–93
   PubMed Web of Science ®Google Scholar
• Gregory DH 2d. Hepatitis B vaccine: key to the era of preventive control. Postgrad Med 1984: 75(1): 199–211
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Antibodies to a retrovirus etiologically associated with acquired immunodeficiency syndrome (AIDS) in populations with increased incidences of the syndrome. MMWR 1984: 33(27): 377–9
   PubMedGoogle Scholar
• Centers for Disease Control. Experimental infection of chimpanzees with lymphadenopathy-associated virus. MMWR 1984: 33(30): 442–3
   PubMedGoogle Scholar
• Gallo RC. The virus. Symposium: acquired immune deficiency syndrome. Proceedings of the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC. 1984
   Google Scholar
• Fauci AS. What it does to the immune system. Symposium: acquired immune deficiency syndrome30
   Google Scholar
• Jacobson IM, Dienstag JL, Zachoval R, et al. Lack of effect of hepatitis B vaccine on T-cell phenotypes. N Engl J Med 1984: 311(16): 1030–2
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Hepatitis B vaccine: evidence confirming lack of AIDS transmission. MMWR 1984: 33(49): 685–7
   PubMedGoogle Scholar
• Dienstag JL, Werner BG, McLane MF, et al. Absence of antibodies to HTLV-III in health workers after hepatitis B vaccination. JAMA 1985: 254(8): 1064–6
   PubMed Web of Science ®Google Scholar
• Saxon A. Hepatitis B vaccine and AIDS. Conference on AIDS (acquired immune deficiency syndrome). Los Angeles (UCLA): 1983
   Google Scholar
• Scolnick EM, McLean AA, West DJ, et al. Clinical evaluation in healthy adults of a hepatitis B vaccine made from recombinant DNA. JAMA 1984: 251(21): 2812–5
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Postexposure prophylaxis of hepatitis B. MMWR 1984: 33(21): 285–90
   PubMedGoogle Scholar
• Centers for Disease Control. Suboptimal response to hepatitis B vaccine given by injection into the buttock. MMWR 1985: 34(8): 105–13
   PubMedGoogle Scholar
• Sherertz RJ, Spindel E, Hoofnagle JH. Antibody to hepatitis B surface antigen may not always indicate immunity to hepatitis B virus infection. (Letter) N Engl J Med 1983: 309(24): 1519
   PubMed Web of Science ®Google Scholar
• Koziol DE, Alter HJ, Kirchner JP, et al. The development of HBsAg-positive hepatitis despite the previous existence of antibody to HBsAg. J Immunol 1976: 117(6): 2260–2
   PubMed Web of Science ®Google Scholar
• Foutch PG, Carey WD, Tabor E, et al. Concomitant hepatitis B surface antigen and antibody in thirteen patients. Ann Intern Med 1983: 99(4): 460–3
   PubMed Web of Science ®Google Scholar
• Johnson BE, Reed JS. Prolongation of the prodrome to acute hepatitis B infection by corticosteroids. Arch Intern Med 1983: 143(9): 1810–1
   PubMedGoogle Scholar
• Rakela J. Fulminant hepatitis: treatment or management? (Editorial) Mayo Clin Proc 1983: 58(10)690–2
   PubMed Web of Science ®Google Scholar
• Scullard GH, Pollard RB, Smith JL, et al. Antiviral treatment of chronic hepatitis B virus infection. 1. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis 1981: 143(6): 772–83
   PubMed Web of Science ®Google Scholar
• Greenberg HB, Pollard RB, Lutwick LI, et al. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 1976: 295(10): 517–22
   PubMed Web of Science ®Google Scholar
• Pollard RB, Smith JL, Neal A, et al. Effect of vidarabine on chronic hepatitis B virus infection. JAMA 1978: 239(16): 1648–50
   PubMed Web of Science ®Google Scholar
• Scullard GH, Andres LL, Greenberg HB, et al. Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside. Hepatology 1981: 1(3): 228–32
   PubMed Web of Science ®Google Scholar
• Scullard GH, Greenberg HB, Smith JL, et al. Antiviral treatment of chronic hepatitis B virus infection: infectious virus cannot be detected in patient serum after permanent responses to treatment. Hepatology 1982: 2(1): 39–49
   PubMed Web of Science ®Google Scholar
• Bassendine MF, Chadwick RG, Salmeron J, et al. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology 1981: 80(5 Pt 1): 1016–22
   PubMed Web of Science ®Google Scholar